Testis refractory cancer
MONDO:0004401Malignant testicular germ cell tumor that is resistant to treatment.
Also known as: refractory cancer of testis, refractory cancer of the testis, refractory malignant testicular germ cell tumor, refractory malignant testicular germ cell tumour, refractory testicular cancer
2787 clinical trials for this condition and its sub-types, 13 tagged with Testis refractory cancer itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
New chemo cocktail targets Hard-to-Treat testicular cancer
Disease control CompletedThis study tests a combination of three chemotherapy drugs—gemcitabine, oxaliplatin, and paclitaxel—in people with advanced testicular cancer that has not responded to standard cisplatin-based treatment or has returned after treatment. The goal is to see if this drug combination …
Phase 2 • Sponsor: University of Southern California • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New drug targets tough childhood cancers with genetic flaws
Disease control CompletedThis phase 2 trial tested the drug samotolisib in 18 children and young adults with advanced solid tumors, non-Hodgkin lymphoma, or histiocytic disorders that had spread, returned, or stopped responding to treatment. Only patients whose tumors had specific mutations in the TSC or…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Personalized chemo dosing aims to beat tough testicular cancers
Disease control CompletedThis phase 2 trial tested a high-dose chemotherapy regimen called TICE in 101 patients with germ cell tumors that had relapsed or were not responding to standard treatment. The approach uses two cycles of paclitaxel and ifosfamide followed by three cycles of carboplatin and etopo…
Phase 2 • Sponsor: Institut Claudius Regaud • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC